Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
about
Nanotheranostics - application and further development of nanomedicine strategies for advanced theranosticsFuture Perspectives of Radionanomedicine Using the Novel Micelle-Encapsulation Method for Surface ModificationMulti-stimuli responsive Cu2S nanocrystals as trimodal imaging and synergistic chemo-photothermal therapy agentsA review of nanoparticle functionality and toxicity on the central nervous systemNeuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicAntibacterial properties of silver nanoparticles in three different sizes and their nanocomposites with a new waterborne polyurethane.Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents.More effective nanomedicines through particle designGold nanotheranostics: photothermal therapy and imaging of Mucin 7 conjugated antibody nanoparticles for urothelial cancer.Nanotechnology and the treatment of HIV infection.Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution.Science of nanofibrous scaffold fabrication: strategies for next generation tissue-engineering scaffolds.Stimulus-responsive targeted nanomicelles for effective cancer therapy.Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.Gold nanoparticles enhance TRAIL sensitivity through Drp1-mediated apoptotic and autophagic mitochondrial fission in NSCLC cellsDesign of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives.Bioceramics: from bone regeneration to cancer nanomedicine.Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives.Perceptive solutions to anti-filarial chemotherapy of lymphatic filariasis from the plethora of nanomedical sciences.Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches.Surface modification of nonviral nanocarriers for enhanced gene delivery.Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics.Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats.Lactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinoma.Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats.Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2.The role of nanotechnology in the treatment of viral infections.Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia.Liposomes and nanotechnology in drug development: focus on oncotargets.Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriageApplication of Various Types of Liposomes in Drug Delivery Systems.Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success.Multifunctional radionanomedicine: a novel nanoplatform for cancer imaging and therapy.Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model.The inhibitory effects of nano-Ag on voltage-gated potassium currents of hippocampal CA1 neurons.Antipsychotic nanomedicine: a successful platform for clinical use.Margination of Fluorescent Polylactic Acid-Polyaspartamide based Nanoparticles in Microcapillaries In Vitro: the Effect of Hematocrit and Pressure.Synthesis of Ferromagnetic Fe0.6 Mn0.4 O Nanoflowers as a New Class of Magnetic Theranostic Platform for In Vivo T1 -T2 Dual-Mode Magnetic Resonance Imaging and Magnetic Hyperthermia Therapy.
P2860
Q26860760-11C6BBE6-2C3F-451C-A24D-979C84765E1AQ27023692-BC0539FE-C1CA-41D4-A91E-F6EF50DA0F61Q27335134-7F5E5D21-8FC6-41C2-9A7B-03855DD76D89Q28383491-0A3C7C99-BD68-4321-B4A6-3FBFD0C5E707Q30394681-DA11EFB5-DC01-4B3A-9C75-80781A979C97Q33740696-D66187BF-4A83-458B-A7B1-D48D488F4C77Q33911056-4BD789DE-5C36-4266-BCC1-D275903F7985Q34440024-B0C072ED-A8D6-4199-94E5-CC6FB7C6AB6FQ35071594-1866A25A-0BF7-45AA-ADF0-457A153CFEF0Q35106115-754F2289-510A-4185-ABED-37ADAE49040EQ35193543-4F2D850D-0F5F-467C-8DD4-45F591357E53Q35943647-E7AB3DE0-77BC-4233-ABD2-1887FE41D8CBQ36461825-89CFA7C1-B729-4E99-9F22-9E983A400479Q37385435-451DA907-5CB2-4AF1-A14F-9C01DF4AE706Q37575475-16B650C9-CB83-40CB-A833-214373B0DDC0Q37639557-FB0DD01D-7D5D-49F0-80C0-92FB3FF6A965Q37739975-8A08D5AA-947E-4059-95DE-518DFA290843Q37834336-60D28624-F58F-48F8-AD79-219E335EF658Q37947163-9B058905-732E-48B6-BC43-8AE6AD1A7520Q38058785-1ABF3C9C-11ED-4436-BB3D-00D704F8C6E0Q38134133-6E5AB79C-4B75-4B48-B70B-B3079CEAA16AQ38136249-C19DDCE7-14A2-4948-B58D-4CFA1790E68FQ38172635-DE7A95E6-1023-4CC0-80F6-12A1065FE805Q38787524-5D75CF83-0C65-4BD6-ABE9-0FEF7DF3A66AQ38830784-440825EF-DF22-4E08-A0F6-A25870DF4B11Q38999820-664ECEA7-3E2E-420C-952B-D26370FEECF9Q39397339-C9CC197D-9FD9-4438-9C10-82C1EB49A280Q39673895-11354A8B-86BE-47D9-A13D-B6F03DC08EA8Q40106774-5BA9BCB6-41FA-46B3-997E-521155A257ABQ40653136-02A07529-E056-4BF2-96CD-9B1993CD146FQ41980659-A4402B8D-197E-4727-808F-BEEEA78964A8Q42116659-617881CC-A0C1-4273-A8E7-84237A9639F5Q42352352-4B7BEE87-F4B6-4441-8A0F-5C66FDF62422Q43563654-0B01E64A-1B56-48D5-B205-F32FC370D0E3Q43594008-118A4201-0972-4240-9A0F-A802188DDCA4Q46024994-50538E87-A9DF-4B7B-8D7E-2D708848EF39Q48165230-CC8F2E4A-EA5F-4CE1-9102-4B567ABCFBE8Q48453772-6756F273-0F08-4F03-A1BF-8835C6A3C2F3Q48599421-CF2A3C09-E15A-4947-99BC-C6C138D70FD6Q51293248-386DF4D4-39C1-41DF-A4E6-AFC4006DD36B
P2860
Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.
@en
Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.
@nl
type
label
Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.
@en
Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.
@nl
prefLabel
Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.
@en
Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.
@nl
P2860
P356
P1433
P1476
Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.
@en
P2093
Madaswamy S Muthu
Sanjay Singh
P2860
P304
P356
10.2217/17435889.4.1.105
P577
2009-01-01T00:00:00Z